A
Avalo Therapeutics, Inc. (AVTX)
NCM – Real Time Price. Currency in USD
18.20
+0.20 (1.11%)
At close: Jun 26, 2026, 4:00 PM EDT
17.84
-0.36 (-1.98%)
After-hours: Jun 26, 2026, 5:30 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
18.20
+0.20 (1.11%)
At close: Jun 26, 2026, 4:00 PM EDT
17.84
-0.36 (-1.98%)
After-hours: Jun 26, 2026, 5:30 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $25.1M significantly exceed its total debt $2.3M, ensuring strong financial flexibility
Total current assets $88.8M exceed Total current liabilities $11.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$17.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.66 | 6.05 | 10 | |
| Quick ratio | 7.66 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 18M | 2M | 441K | 59K | 59K |
| Gross Profit | 15M | 640K | 638K | -285K | -167K |
| Operating Income | -37M | -23M | -41M | -73M | -79M |
| Net Income | -42M | -32M | -35M | -78M | -85M |
| EBITDA | -37M | -23M | -41M | -73M | -79M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 67.9 | 5.5 |
| Next quarter | N/A | 75.13 | 5.5 |
| Current year | -100 | 47.12 | 5.5 |
| Next year | N/A | 1.73 | 2.0 |
| Weighted average score | 4.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -43.07 | -30.66 | -24.17 | 1.0 |
| Y/Y | 999 | -49.28 | 21.6 | -87.06 | 5.5 |
| 3y average | -84.33 | -36.61 | 81 | -26.26 | 3.3 |
| 5y average | -7.59 | -18.4 | 60.63 | -18.29 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |